Top 50 Life Science VC (Venture Capital) Funds in Israel in April 2025
A list of 50 VC (Venture Capital) funds that invest in Life science startups based in Israel. We rank investors based on the number of investments they made in Life science companies from Israel. We update this investor list every month.Top 50 Life Science VC (Venture Capital) Funds in Israel in April 2025
Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies.
Our golden eggs
Ayana Pharma
A late stage company with
Show more
Investment focus
- Biotechnology, Pharmaceutical, Life Science
- Seed, Series B, Series F
- Israel
Portfolio highlights
- BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
- Splisense — Transformative RNA Based Treatments -Antisense Oligonucleotides- Targeting the Root Cause of Pulmonary Diseases Our innovative RNA based therapies, based on Antisense Oligonucleotides (ASOs), restore and modify protein functionality, addressing untreatable pulmonary diseases.
- Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria
Early Stage VC
Show more
Investment focus
- Software, Biotechnology, Machine Learning
- Seed, Pre-Seed, Series A
- Israel, United States, United Kingdom
Portfolio highlights
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
- Lidwave — Lidwave’s deep-tech solution revolutionizes 3D sensing and the verticals relying on it by examining the biggest challenge in LiDAR technology from a new perspective, free of bandwidth limitations.
- DeepCure — DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools and automation to discover novel small molecules for challenging targets. DeepCure currently has a lead asset in IND-enabling studies and other programs focused on drugging intractable targets that have t
The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.
Show more
Investment focus
- Health Care, Medical Device, Biotechnology
- Grant, Seed, Pre-Seed
- Israel, United States, Mali
Portfolio highlights
- i-EcoGuard — I-Ecoguard is pioneering sustainable agriculture with cutting-edge nanoparticle technology. Our objective is to improve greenhouse efficiency, plant health, and crop quality.
- Eretz Angels — Eretz Angels supports technology startups in Israel's outskirts at the start of their journey.
- Lowental Hybrid — Lowental Hybrid technology combines fuel-based propulsion with electric power, enabling longer operating hours while preserving the low noise levels characteristic of electric systems.
Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech.With two offices in Israel, Pitango currently managesseveral venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.
Show more
Investment focus
- Software, Health Care, Information Technology
- Series A, Series B, Series C
- Israel, United States, China
Portfolio highlights
- Homethrive — Homethrive is dedicated to helping families care for their loved ones who are aging or have special needs. Discover how our caregiving solution, Dari, can help you!
- Guardoc Health — Streamlining clinical compliance with AI-driven accuracy in charting to meet regulations, enhance patient care, and optimize revenue management.
- Quantum Source — Quantum Source is on a clear path to the most powerful, cost-effective, practical photonic quantum computer. Learn more.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- United States, China, Israel
Portfolio highlights
- vVardis — vVardis is a personal oral care brand by Dres Abivardi.vVardis is both the professional dental CURODONT™ line and the oral care vVardis products – both with the proprietary CUROLOX® & WX Technology – will form one oral care powerhouse.
- Stairway Medical — Stairway Medical is a developer of implantable brain-computer interface technology.
- Helicore Biopharma — Helicore Biopharma is at the forefront of developing cutting-edge treatments for obesity and related disorders.
fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio.
It's never too early to have a conversation about your startup.
Show more
Investment focus
- Health Care, FinTech, E-Learning
- Seed, Pre-Seed, Series A
- Israel, United States, Norway
Portfolio highlights
- Chamelio — Chamelio builds intelligent technology for in-house legal teams. We understand that every in-house legal team operates uniquely - shaped by their industry context, company culture, and strategic priorities. Our platform adapts to these distinct characteristics, delivering hyper-personalized workflows that evolve with your team's specific needs.
- Vayu — Discover Vayu, the cutting-edge billing and revenue management platform designed to streamline operations and maximize efficiency for finance teams.
- Guardoc Health — Streamlining clinical compliance with AI-driven accuracy in charting to meet regulations, enhance patient care, and optimize revenue management.
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Series C
- United States, Israel, France
Portfolio highlights
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
- Indapta Therapeutics — Indapta Therapeutics is a privately held biotechnology company developing an NK (natural killer) cell therapy platform for the treatment of blood and solid tumor cancers.
PeakBridge is a global impact VC that funds and connects the people, technology and processes that will shape the future of food.
Show more
Investment focus
- Food and Beverage, Food Processing, Health Care
- Series A, Seed, Funding Round
- Israel, United States, United Kingdom
Portfolio highlights
- BE WTR — The first premium sustainable water brand aiming to promote a more ecological water consumption and to contribute to a better hydration thanks to its technological and design water systems. | Discover more about us.
- Mondra — AI-driven environmental insights platform that supports food system players to accelerate Scope 3 progress, reduce the cost of Net Zero, and drive competitive advantage.
- Orbisk — One-third of all food produced (worldwide) is wasted. Orbisk helps professional kitchens to get a grip on their food waste.
Grove Ventures is a leading early-stage venture capital fund in Israel. It partners early with exceptional Israeli founders who believe th...
Show more
Investment focus
- Artificial Intelligence, Machine Learning, Software
- Seed, Series A, Series B
- Israel, United States
Portfolio highlights
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
- Wing Cloud — Wing Cloud tames cloud complexity through a unified programming and operational model that works across all providers and services.
- Quantum Source — Quantum Source is on a clear path to the most powerful, cost-effective, practical photonic quantum computer. Learn more.
Investing with conviction in visionary, technical founders inventing the future.
Show more
Investment focus
- Software, Artificial Intelligence, Biotechnology
- Seed, Pre-Seed, Series A
- United States, Canada, Israel
Portfolio highlights
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
- Bot Auto — Bot Auto develops and operates autonomous trucks for middle-mile freight.
- Phaseshift Technologies — Phaseshift Technologies is developing a Computational Materials Engineering (CME) platform to help accelerate the Research and Development of High-Performance Alloys. The CME platform is driven by Quantum Chemistry calculations and aided by Machine Learning based predictive algorithms.
Minrav provides engineering and construction services.
Show more
Investment focus
- Health Care, Hospital, Wellness
- Series A, Funding Round
- Israel, Malaysia
Portfolio highlights
- iwi Life — Algae is the ultimate source of Omega-3s. Research has proven that Omega-3s support cardiovascular health, a balanced mood, and healthy brain development.
- Qualitas Health — Qualitas Health Group aims to serve patients through a network of 500 clinics by 2022 with quality healthcare services across the Asia Pacific.
Genesis Park is a Houston-based private equity firm focusing on buyouts, partnering strategies with public corporations, and growth financing. We bring capital, commercial execution capabilities and a depth of experience in mergers and acquisitions.We are opportunistic within market sectors where we have depth and exposure. Those sectors includetelecommunications, energy technology and media. Energy technology is a rapidly expanding category, and our Houston base allows us to marry traditional and alternative techniques in upstream and downstream environments. Founded in 2000, Genesis Park has used discipline and patience to build value for our investors, regardless of prevailing market conditions. We are consistently active in our portfolio companies, listening, learning and adding value by working alongside management. While our preference is to partner with an existing management team, we commonly source additional talent to optimize the existing opportunity.
Show more
Investment focus
- Manufacturing, Construction, Health Care
- Private Equity, Debt Financing, Funding Round
- United States, Israel
Portfolio highlights
- The Good Feet Store — Discover comfort and foot pain relief with The Good Feet Store arch support inserts. Clinically proven - improve body alignment and overall foot health.
- WESTCO GROUNDS — Westoco Provides Landscaping is a highly competitive industry, and Westco continues to thrive because it tailor services to specific client needs and deliver complete solutions with dependability,Rainbird facilitate quick responses and ressources.
- Conditioned Air — Trust Conditioned Air for expert HVAC services in Southwest Florida. We offer AC repair, replacement, heating solutions, and indoor air quality services.
FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.
Show more
Investment focus
- Biotechnology, Life Science, Biopharma
- Seed, Funding Round
- Israel
Portfolio highlights
- Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
- Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
- Bsense Bio Therapeutics — Bsense Bio Therapeutics is developing small molecules for the treatment of neuropathic pain. Bsense is pioneering a novel approach targeting multiple pain-related mechanisms using a single compound, to achieve greater efficacy and safety.
Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Funding Round
- United States, United Kingdom, Israel
Portfolio highlights
- Be Biopharma — Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.
- Larkspur Biosciences — Larkspur's strategy focuses on the particular ways in which tumours hijack the immune system by developing precision immunotherapies for molecularly defined patient groups to overcome the bottlenecks that allow the tumour to subvert the immune system.
- EvolveImmune Therapeutics — EvolveImmune Therapeutics transforms the discovery and development of novel immunotherapies. By leveraging its proprietary in vivo target discovery platform, EvolveImmune is building a pipeline of novel therapeutic candidates against numerous targets that are expressed on multiple immune cell types. The company’s platform will generatefirst-in-class treatments for unmet needs in oncology and autoimmune diseases.
Cancer Focus Fund is an investment firm that is dedicated to providing financial services to its clients.
The company was founded by Ross Barrett.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Funding Round, Seed, Series A
- Israel, United States, Germany
Portfolio highlights
- Eisbach Bio — Eisbach Bio is a biotechnology company that creates new drugs that target molecular vulnerabilities in cancer genomes. Screening and cellular platforms are yielding first-in-class inhibitors to directly target the key vulnerability found in genetically defined tumors. It is founded in 2019 and is based in Martinsried, Bavaria.
- March Biosciences — Transforming Patient Care by Unlocking New Target Spaces March Biosciences is a clinical-stage company in the cell therapy field focused on developing CAR-T cell strategies to address the most challenging hematological cancers Pipeline MB-105 https://march.bio/wp-content/uploads/2023/05/shutterstock_1008023995-HD-30.mp4 Focused on Excellence Target Space Our approach combines biological and engineering insights to enable target-unlock without the risk and complexity
- Starget Pharma — Starget Pharma develops a new generation of targeted radiopharmaceutical technologies for the treatment of solid tumors. Starget Pharma has a pipeline of novel targeted radiopharmaceutical molecules that act as a vector for selectively transferring radioisotopes to cancer tumor tissues.
Arancia International Inc is a part of Arancia Group in Mexico. We are long term investors in food, nutrition and biotechnology companies.
Show more
Investment focus
- Health Care, Biotechnology, Life Science
- Series A, Series B, Funding Round
- Israel, United States, Malaysia
Portfolio highlights
- NextFerm — NextFerm is a science oriented industrial company, representing a new era in fermentation and fermentation-derived nutrients for supplements, food, infant nutrition and animal feed.The world is striving for better nutrition. Nutrition which is less artificial and more natural, sustainable and cost effective - with a much higher nutritional value.At Nextferm, they aim to use their capabilities to lead this new and exciting world of better nutrition.
- iwi Life — Algae is the ultimate source of Omega-3s. Research has proven that Omega-3s support cardiovascular health, a balanced mood, and healthy brain development.
- The Mediterranean Food Lab — The Mediterranean Food Lab merge traditional fermentation and cutting-edge science, to produce natural plant-based flavor-bases for a wide range of meat replacement needs.
Neo Ventures is the first open-ended early stage investor, based in Eastern Europe. The founders have backed more than 30 startups and exited 10 successfully. We invest in game-changing businesses, without geographic limitations. We partner with exceptional founder teams to challenge incumbents in markets ripe for change or to create entirely newmarkets. Neo Ventures funds and then supports the founders in business planning, scaling operations, follow-on investments, making the best of each opportunity and dealing with hard situations. Our investment focus is on data analytics, computer vision and remote sensing addressing disruptive opportunities across the high-growth SpaceTech, BioTech and Security verticals.
Show more
Investment focus
- Software, Artificial Intelligence, Aerospace
- Seed, Funding Round, Series A
- Israel, United Kingdom, Estonia
Portfolio highlights
- EnduroSat — At EnduroSat, we engineer, build and operate exceptional satellites. Our Mission is to make space universally accessible
- Cyberwrite — TRUSTED BY INDUSTRY LEADERS One platform to accelerate value across the cyber insurance lifecycle THE LATEST FROM CYBERWRITE
- GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.
Healthcare innovation wherever it originates.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- United States, Israel, United Kingdom
Portfolio highlights
- Moon Surgical — Create the OR of the future, one that is sustainable, efficient, and digitalized.
- Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with Artera. Transforming cancer therapy through innovation.
- ONL Therapeutics — ONL Therapeutics develops innovative therapeutics to protect and improve the vision of patients with a range of retinal diseases and conditions.
aMoon is a leading healthtech & life sciences venture capital firm.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series B, Series A, Funding Round
- United States, Israel, Switzerland
Portfolio highlights
- Lyfegen — Lyfegen is the first of its kind, a company making value-based healthcare contracting for high-cost therapies a reality for all healthcare stakeholders.
- PrognomiQ — PrognomiQ is invested in transforming the detection and early treatment of cancer and other complex diseases. Learn more about our test products and careers.
- MetaSight Diagnostics — MetaSight Diagnostics, a health technology company, is on a mission to develop affordable and precise liquid biopsy diagnostics for the early detection of a wide range of chronic and acute diseases by leveraging proprietary mass spectrometry technologies (metabolomics, lipidomics, and proteomics).
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates.
HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Seed, Convertible Note, Pre-Seed
- United States, India, United Kingdom
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Global impact fund focusing on biotech, medtech and agritech investments that make a difference
Show more
Investment focus
- Medical, Health Care, Life Science
- Funding Round
- Israel
Portfolio highlights
- Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
Remiges Ventures is a venture capital firm that focuses on groups and businesses in the Japanese academia and pharmaceutical industry.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Series A, Series B, Seed
- United States, Japan, Canada
Portfolio highlights
- Immunis — Currently seeking participants for age-related muscle atrophy (sarcopenia) clinical trails
- Cyrano Therapeutics — Cyrano Therapeutics is the leader in Smell Loss therapy and smell loss research. Recover your sense of smell today!
- KisoJi Biotechnology — KisoJi is a leading next-generation antibody company developing multi-specific antibodies to address difficult targets in oncology and other diseases
Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Funding Round, Series A, Series B
- Israel
Portfolio highlights
- ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
- Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Life Science Angels, Inc. (LSA) is the premier angel investment group focused solely on healthcare investing, including medical devices, diagnostics, pharmaceuticals, biotechnology, and digital health.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Funding Round, Seed, Series A
- United States, Israel, The Netherlands
Portfolio highlights
- Neurava — Neurava has developed wearable diagnostics for epilepsy patients including those at risk of SUDEP. The company specializes in the fields of medical device manufacturing, healthcare, and health diagnostics.
- Flyte — Flyte promotes cellular healing in pelvic floor muscles for lasting results. Flyte is fast, proven, safe, pelvic floor therapy for bladder control.
- Trio Pharmaceuticals — Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors. These drugs directly stop tumor growth and selectively stop immunosuppression in the tumor without targeting the current immune checkpoint pathways. The company was founded in 2018 and is headquartered in San Diego, California.
Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.
Show more
Investment focus
- Biotechnology, Health Care, Medical Device
- Seed, Funding Round, Series A
- Israel, Singapore, United Kingdom
Portfolio highlights
- AgriG8 — AgriG8 is an enterprise designed to align, collaborate, de-risk and grow value chains and ecosystems within the agricultural industry.
- Peptobiotics — We make agriculture more productive, humane and sustainable by promoting growth and protecting against pathogens using a new new type of antibiotic alternative that does not cause resistance. Our recombinant peptides are synthetic biology products manufactured in a patent pending precision fermentation process. We are launching a range of products across livestock and aquaculture in Asia.
- Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
OTV focuses on round A+ startups that aim to make a significant impact on people's lives. Our focus is on entrepreneurs with innovative ideas who are advancing the global state of well-being. Come join the digital health revolution, and be a part of transforming the healthcare industry.
Show more
Investment focus
- Health Care, Medical, Artificial Intelligence
- Series A, Series B, Seed
- United States, Israel, Ghana
Portfolio highlights
- Scopio — Buy & sell images on the largest Solana Photography NFT Marketplace. Find high-quality stock images & hire artists from around the world.
- Scopio Labs — Scopio Labs is a provider of Full Field Morphology dedicated to unlocking the potential of imaging and AI in hematology. Uncovering actionable insights from vast amounts of data readily available in the average blood sample and bone marrow aspirate, Scopio's solutions will aim to showcase thousands of cells at scale in high resolution, toenable new hematology diagnostic methods.
- Stake — Renters earn Cash back for rent. Building operators outperform the market. That's the Stake win-win. Find out how we're building the financial tools for the next generation of rentals.
TPY Capital is a Tel Aviv based early state VC, investing in some of Israel’s most talented entrepreneurs. They are active investors who typically lead rounds in the areas we invest in, which include data and analytics, digitization and human augmentation, fintech, and frontier tech such as quantum computing.
Show more
Investment focus
- Software, Artificial Intelligence, Big Data
- Seed, Series A, Series B
- Israel, United States, France
Portfolio highlights
- Tabnine — Tabnine is an AI code-completion tool that helps developers worldwide write better code faster.
- Kodem Security — Providing users with runtime intelligence to grasp the relevant application risks.
- DOT Compliance — Harness the power of the AI-powered solution built for quality and compliance in life sciences. Get a demo of Dot Compliance.
Arc Impact is a venture capital firm.
Show more
Investment focus
- Health Care, Food and Beverage, AgTech
- Seed, Pre-Seed
- Israel, United States, United Kingdom
Portfolio highlights
- Behavidence — Behavidence is a mental health application that generates a daily mental health score. It compares your digital behavior to other people with anxiety, depression and ADHD.
- MadeRight — We usher in a new era of sustainable fungi-based materials that deliver excellent performance. The future, as we see it, is a novel industrial chain based on biomaterials.
- Virtual Internships — The only platform that guarantees real-world work experience across the globe to shape tomorrow's workforce.
Sectoral is specialized in managing equities globally in the healthcare sector. Founded in October 2000, we are SEC-registered as an investment advisor. 100% employee-owned, we have offices in Montreal, Geneva, and Hong Kong.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series C, Post-IPO Equity
- United States, United Kingdom, France
Portfolio highlights
- Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
- Phagenesis — Phagenesis offers non-surgical neurostimulation therapy to restore swallowing control and reduce length of stay.
- LENZ Therapeutics — LENZ Therapeutics is is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision, focused on an eye drop to treat presbyopia and provide seamless vision for the vast majority of presbyopes.
Pfizer provides access to safe and effective and affordable medicines and health care services. They have a portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas; and they have an industry-leading pipeline of promising new products that havethe potential to challenge some of the most feared diseases of their time, like Alzheimer's disease and cancer.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Post-IPO Equity, Series A, Seed
- United States, Israel, France
Portfolio highlights
- CytoReason — CytoReason is a tech company developing a computational model of the human body. The company collects proprietary data from pharma companies and uses it to simulate human diseases – tissue by tissue, cell by cell. With CytoReason’s massive database and AI-led platform, pharma and biotech companies identify new opportunities, shorten trial phases,reduce development costs and increase the likelihood of approval. To date, six of the world’s top ten pharma companies use CytoReason’s technology.
- AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.
- EvolveImmune Therapeutics — EvolveImmune Therapeutics transforms the discovery and development of novel immunotherapies. By leveraging its proprietary in vivo target discovery platform, EvolveImmune is building a pipeline of novel therapeutic candidates against numerous targets that are expressed on multiple immune cell types. The company’s platform will generatefirst-in-class treatments for unmet needs in oncology and autoimmune diseases.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United States, United Kingdom, Switzerland
Portfolio highlights
- IonKraft — IonKraft can provide better performance at a lower cost while maintaining recyclability, they also promote material reduction and reuse and are commercializing the technology with funding from the German Federal Ministry for Economic Affairs and Energy (BMWi).
- NovoLINC — NovoLINC is a pioneering startup that provides thermal interface solutions. It develops a distinctive system of nanostructured materials and a proprietary manufacturing process with the objective of transforming thermal management.
- TRIMTECH Therapeutics — TRIMTECH Therapeutics is a biotech organization that treats neurodegenerative illnesses by using targeted protein degradation (TPD).
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United States, Germany, Belgium
Portfolio highlights
- Aignostics — Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of preciseheatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.The company was founded in 2018 and is headquartered in Berlin, Germany.
- Glox Therapeutics — Developing novel precision antibiotics based on protein bacteriocins, to target Gram-negative Antimicrobial Resistant (AMR) pathogens.
- Asgard Therapeutics — Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biologicalproperties of professional antigen-presenting cells.
Investment Banking Boutique
Since 1978
Show more
Investment focus
- AgTech, Medical, Cannabis
- Series A
- Israel
Portfolio highlights
- GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.
GoodPaper Ventures is a venture capital company that offers private equity and investment management services.
Show more
Investment focus
- Legal, Legal Tech, E-Signature
- Series A
Portfolio highlights
- OneNotary — Looking for a reliable and convenient online notary service? OneNotary platform offers fully legal and secure notarization services in all 50 states.
- Foresee Genomics — Foresee Genomics creates comprehensive solutions, including as protocols, reagents, and bioinformatics tools, to make NGS available to small and medium-sized facilities. Its objective is to enable these labs to conduct high-accuracy genomic analysis independently, without the requirement for expensive infrastructure or large minimum quantities. Byspeeding the sequencing procedure and minimizing per-sample expenses, Foresee Genomics enables laboratories to provide quick, precise insights that support tailored patient care.
Khosla Ventures invests in companies that are bold, early, and impactful. The firm was started in 2004 by Vinod Khosla, co-founder of Sun Microsystems, to provide venture assistance to entrepreneurs.Khosla Ventures invests in a range of areas including AI, climate, sustainability, enterprise, consumer, fintech, digital health, medtech anddiagnostics, therapeutics, and frontier technology.
Show more
Investment focus
- Software, Health Care, Artificial Intelligence
- Series A, Series B, Seed
- United States, India, United Kingdom
Portfolio highlights
- Onyx — The open-source AI enterprise search platform that helps teams find information across all company data.
- Tempero Bio — Tempero Bio develops treatments for Substance Use Disorders as a clinical-stage biopharmaceutical company.
- Resource Chemical — Resource Chemical develops CO2 into high-performance plastics that do not pollute the environment. The company's headquarters are in Berkeley, California.
Rationalwave Capital Partners is a venture capital firm investing in technology companies both public and private. The firm is located in New York and founded by Mark Rosenblatt in 2003.
Show more
Investment focus
- Machine Learning, Artificial Intelligence, Analytics
- Seed, Pre-Seed, Funding Round
- United States, Israel, Trinidad and Tobago
Portfolio highlights
- Aromyx — Aromyx pioneers the creation of tastes and smells using a quantitative measurement system developed with biotechnology, data science, and AI.
- Brij — With one-touch, BRIJ allows consumers to gain product info, care instructions and discounts while you gain a deeper understanding of your consumer. Apps, paper manuals and hassles not required.
- BactoByte LTD — BactoByte aims to empower caregivers with one-hour bacterial diagnostics and antibiotic screening capability to improve outcomes, reduce mis-diagnostics, and lower health care costs.Based on a proprietary novel basic method, BactoByte’s assay delivers precise and cost-effective identification and direct antibiotics susceptibility testing with80-90% improvement of standard turnaround time.Time reduction, sensitivity, and specificity results in decreased mortality rates, fewer hospital days, and avoidance of associated costs of $1K-50K per patient.BactoByte has technology validation and partnerships with leading medical centers.
Arix Bioscience is a global healthcare and life science company that drives value in private and public companies through operational and strategic direction as well as patient capital
Their extensive experience in academic science, clinical and commercial strategy, company operations, mergers and acquisitions, venture capital and corporate financeputs them in an especially strong position to build and support a wide range of businesses and technologies.Arix Bioscience has privileged agreements with leading universities in the UK, Europe and Australia, providing direct access to innovative new technologies. They also have access to a broad range of research projects from US academic institutions.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series B, Series A, Series C
- United States, France, Israel
Portfolio highlights
- Ensoma — Ensoma is expanding the reach of the curative power of genomic medicine by pioneering a next-generation in vivo approach using its Engenious™ vectors. Ensoma’s vectors are designed to deliver a diverse range of gene modification technologies without the need for stem cell collection or prior myeloablative conditioning (e.g., chemotherapy). As aresult, Ensoma’s therapies can be delivered as a single injection in a diverse range of settings, including outpatient and settings where access to sophisticated healthcare systems may be limited.
- Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
- Disc Medicine — Disc Medicine is led by an experienced team of scientists and industry experts, and supported by a panel of advisors with a strong track record of discovering and developing new and innovative therapies. Disc Medicine was founded by Atlas Venture and Brian MacDonald, with Novo Ventures and Access Biotechnology joining as additional investors.
The Land of Milk and Honey is an abundant location where life is simple and devoid of need. Both in brand-new real estate development projects and while professionally restoring and renovating houses, Milk and Honey Investments LLC aims to create distinctive spaces of abundance and healthy living.
Show more
Investment focus
- Life Science, Organic Food, Biotechnology
- Series A
- Israel
Portfolio highlights
- BioBetter — BioBetter is a foodtech company that develops plant-based platforms for the production of complex growth factors used in cultivated meat. The company was founded in 2015 and is headquartered in Israel.
Angel
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Pre-Seed, Seed, Series A
- United States, United Kingdom, Singapore
Portfolio highlights
- Vytal.ai — Vytal allows for brain health evaluation in minutes with just a laptop. Take control of your cognitive health.
- Akhetonics — Creating the first all-optical RISC Processor
- Greena World — In a world where travel connects us, we often overlook the impact we leave behind. Tourism accounts for over 8% of global CO2 emissions. Beyond environmental challenges like deforestation, pollution, and water scarcity, local communities also face pressure, experiencing changes in their traditions and ways of life.With expertise from SwanseaUniversity and the United Nations, our team recognised these challenges and envisioned a world where travel helps, not harms. Introducing Greena World. More than just a piece of technology, it's a guide for hotels and restaurants, helping them understand, improve, and share their impact on both the environment and local communities.The true beauty of embracing sustainability? The rewards. With the Greena Index, businesses can improve their sustainability and, in doing so, unlock a new market of over 100+ million eco-conscious travellers, boost revenues, and save on operating costs.The sustainable tourism sector is rapidly expanding, currently valued at $75B and witnessing a growth rate of 9.7% each year. While our initial focus is on hotels and restaurants, the Greena Index has ambitions to reshape the entire spectrum of the industry, from airlines to activities and destinations.Join us on a mission to transform the entire tourism industry for many generations to come.
ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Funding Round, Series B
- Israel, United States
Portfolio highlights
- Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
- Append Medical — A novel transcatheter LAA elimination system
- Gina Life — At Nevia bio, we are focused on women's health. Our mission is to use innovative technologies to provide early detection of diseases through vaginal secretions analysis, enabled by Nevia's Machine Learning Platform.
Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI)
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Funding Round, Series B
- Israel, United States
Portfolio highlights
- Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
- Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
- Elicio Therapeutics — Elicio ground-breaking Amphiphile technology is engineering potent vaccines and immunotherapies to defeat an array of aggressive cancers.
Trust Ventures is a venture capital firm that focuses on startups and provides knowledge and expertise in incumbent-heavy industries. The firm was founded in 2018 and is based in Austin, Texas, United States.
Show more
Investment focus
- Information Technology, Health Care, Software
- Seed, Series A, Series B
- United States, Brazil, Israel
Portfolio highlights
- Justpoint — Justpoint is a venture-backed AI-first company redesigning the medical malpractice industry. Our first product allows for a faster and better understanding of the legal merits of a claim as well as an instant understanding of its likely settlement amount.We have previously created companies that effectively changed their industries, fromhealthcare insurance to clinical trial recruitment. To advance the medical malpractice industry, we have put together a team with extensive achievements in healthcare technology, medical malpractice litigation, and artificial intelligence.
- Harbor — Harbor offers the first and only baby monitoring system with a dedicated, local Monitor that works without internet and securely connects to the cloud if and when you want it to, allowing you to access remotely with failsafe notifications. Learn why Harbor is better than Nanit & Owlet at harbor.co!
- GreenLite Technologies — GreenLite makes getting a construction permit fast, predictable, and transparent. Let the GreenLite Platform handle your permitting needs so you can focus on growing your business.
Morningside makes venture capital investments in companies with novel science and technology. We are characterized by a long-term outlook in company-building and an unwavering commitment to acting ethically.Based in the greater Boston area, our team of entrepreneurial investment professionals has deep experience in life sciences, digital health,AI, materials and technology.Founded in 1986 as a family office for the Chan family, charitable commitments to education, research and healthcare include the Harvard T.H. Chan School of Public Health, the UMass Chan Medical School, and the MIT Morningside Academy for Design.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Series C
- United States, United Kingdom, China
Portfolio highlights
- Xealth — Connect your digital health vendors so doctors can order, deliver and monitor care from a single digital health integration platform.
- AdvanCell — AdvanCell is an Australian radiopharmaceutical firm in the clinical stages that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.
- SimpliFed — SimpliFed provides virtual breastfeeding and baby feeding support fully covered by your health plan from pregnancy to weaning.
RMGP Biopharma Investment Fund is an investment Fund
Show more
Investment focus
- Biotechnology, Biopharma, Health Care
- Seed, Series B, Funding Round
- Israel
Portfolio highlights
- Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
- Pi Therapeutics — Pi Therapeutics is a discovery-stage biopharmaceutical company aiming to develop a novel cancer drug. The company is financed by a syndicate of Takeda Pharmaceutical Company through its venture group Takeda Ventures Inc., Johnson & Johnson Innovation – JJDC, OrbiMed Israel Partners, Pontifax, and the Israel Innovation Authority, and hasoperated since March 2015 in the FutuRx biotech accelerator in Ness Ziona, Israel. The company’s mission is to develop novel first-in-class drugs directed against the ubiquitin-proteasome system (UPS), mainly for treatment of cancer.
- Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
Impacting the future of medicine.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- United States, United Kingdom, The Netherlands
Portfolio highlights
- Numab — Numab Therapeutics AG
- Verdiva Bio — Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications achieve better outcomes via more patient-friendly therapeutic options.
- Orbis Medicines — Orbis Medicines is a novel macrocyclic chemistry and computational platform for high-throughput drug discovery.
Talisman Capital Partners operates as a private investment company.
Show more
Investment focus
- Information Services, Pet, News
- Series A, Seed, Series B
- United States, Israel, Hong Kong
Portfolio highlights
- Bond Vet — We offer compassionate, thorough, & friendly pet care in a warm, comfortable environment. Walk in or book online.
- Prilenia — Prilenia is a clinical-stage biotech company that develops novel treatments for neurodegenerative and neurodevelopmental disorders. Its lead asset is Pridopidine, a n oral drug candidate with an established safety profile and potential in multiple movement disorders and neurodegenerative diseases affecting adults and children.The company wasfounded in 2018 and is based in Israel, the Netherlands, and Boston.
- qServe Communications — At qServe Communications, it is their unique vision to be a one-stop source for all your maintenance and development needs. They understand the difficulty of locating reliable companies to meet all of your infrastructure requirements. qServe has built an answer to this problem, a national service network of in-house employees to deliver qualitymanagement, installation, erection, inspection and maintenance services to the communications industry.With their full spectrum of project and program management services, they drive your project from start to finish, becoming an integral part of your development team. Many of qServe Communications crews and staff bring many years of valuable experience in the development of communications systems and infrastructures. From Program and Project Management to in-house installation and maintenance services, qServe will work diligently to ensure your project's success.qServe has performed thousands of projects for clients including: AT&T Wireless Services, Alltel Mobile, Nextel, Sprint, Omnipoint, Bell Atlantic Mobile, Teligent, Metricom, American Tower, Crown Castle and SBA Communications Corporation.
We focus on advances in medical technology and digital health to change the face of healthcare.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series B, Series C, Series A
- United States, Israel
Portfolio highlights
- TailorMed — Moving Mountains for Patients
- Alto Neuroscience — We leverage brain biology to develop personalized medicines, helping patients get better faster.
- Clever Care Health Plan Inc. — Clever Care delivers culturally sensitive Medicare options in Southern California that honor and represent the cultural values of the communities we serve. Health and wellness, centered around you.
The Office of the Chief Scientist [OCS] in the Ministry of Economy is charged with execution of government policy for support of industrial R&D. The goal of the OCS is to assist in the development of technology in Israel as a means of fostering economic growth, encouraging technological innovation and entrepreneurship, leveraging Israel’sscientific potential, enhancing the knowledge base of industry in Israel, stimulating high value-added R&D and encouraging R&D collaboration both nationally and internationally. A variety of ongoing support programs developed and offered by the OCS play a major role in enabling Israel to be a key center for high tech entrepreneurship.
Show more
Investment focus
- Health Care, Biotechnology, Hardware
- Seed
- Israel
Portfolio highlights
- LapSpace — LapSpace Medical was founded in 2011. It operates within the framework of the Misgav Venture Accelerator, part of The Trendines Group. The LapSpace team combines strong business and medical experience and knowledge.
- Digma Medical — Digma Medical | DiaGone - safe, one-time, 30 minute, minimaly-invasive, GI procedure for Restoring Glycemic Control for T2DM & NASH patients | No Implant
- Immunovative Therapies — Immunovative Therapies is a biopharmaceutical company with financial support of the Israel Office of the Chief Scientist. ITL is a graduate of the Misgav Venture Accelerator, a member of the world renown Israel technological incubator program. The company was the Misgav Venture Accelerator's candidate for the prize for the outstandingincubator project of 2006, awarded by the Office of the Chief Scientist. They specialize in the development of novel immunotherapy drug products that incorporate living immune cells as the active ingredients for the treatment of cancer and infectious disease.
JVP is a top VC firm with $1.9B AUM and 165 companies built, leading in AI, Cyber Security, Fintech, Insurtech and Climatech.
Show more
Investment focus
- Software, Cyber Security, Enterprise Software
- Series A, Series B, Seed
- United States, Israel, United Kingdom
Portfolio highlights
- Datricks — Offering real-time risk detection and control, ensuring continuous financial compliance and enabling you to significantly impact the bottom line of your business
- Greeneye Technology — Spray Less, Grow More. Our mission is to dramatically reduce chemicals usage while increasing productivity and profitability for farmers.
- Secret Double Octopus — Provider of industry-leading FIDO-certified, rotation-based passwordless MFA with the fullest support for enterprise complexity. Click here for more!
SICAR
Show more
Investment focus
- Medical, Health Care, Life Science
- Series C, Funding Round
- Israel, Germany
Portfolio highlights
- Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
- OMEICOS Therapeutics — OMEICOS Therapeutics is developing a novel, first-in-class, small molecule utilizing a new Mode of Action. OMEICOS' novel therapeutic strategy is based upon the discovery of natural metabolites of omega-3 fatty acids that mediate a strong anti-arrhythmic effect. In contrast to all other anti-arrhythmic drugs, OMEICOS' substances activatean endogenous cardio-protective signaling pathway that not only stabilizes the heart rhythm but shall provide curative effects to the diseased organ by preventing its electrical and structural remodeling.
Investors by industry
Proptech
Impact
Hardware
Gaming
Google
Consumer
Energy
Climate
Marketplace
FinTech
Health Care
Community
Artificial intelligence
EdTech
Sustainability
Venture Capital
Organic Food
Real Estate
Web3
Big Data
Education
Finance
Video Games
Payments
Publishing
Food and Beverage
Financial Services
Retail
Clean Energy
B2B
Photography
Infrastructure
Beauty
Social Media
Android
Art
Digital Media
Social Network
Franchise
Construction
Local
eSports
Legal
Enterprise Software
Biotech
Platforms
Mobile Advertising
Recruiting
Biotechnology
Hospitality
Cannabis
Fitness
Travel
Automotive
Wine And Spirits
Medical Device
Crowdfunding
Social
CleanTech
Mobile Apps
Transportation
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Theatre
Film
Life Science
Non Profit
Renewable Energy
SaaS
Internet
Sports
Medical
Email
Wellness
Music
Manufacturing
Mobile
Sporting Goods
Celebrity
Restaurants
Social Impact
Software
Cryptocurrency
Blockchain
Machine Learning
Agriculture (agtech)
Media (entertainment)
Facebook
Investors by country
Germany
United Kingdom
India
New Zealand
Canada
Ireland
Australia
United States
South Korea
China
Oceania
Japan
Sri Lanka
Singapore
Europe
Indonesia
South Africa
Vietnam
LATAM
Spain
Armenia
Brazil
Africa
Middle East
Georgia
Ecuador
Bahrain
Faroe Islands
Belize
Egypt
Croatia
Qatar
Greece
Ghana
Asia
Hungary
Finland
Estonia
Costa Rica
Czech Republic
Ethiopia
France
Belgium
Saudi Arabia
Hong Kong
Barbados
Gibraltar
Bermuda
Belarus
Algeria
Chile
Denmark
Liberia
Bulgaria
Tajikistan
Togo
Seychelles
Poland
Zimbabwe
Tanzania
Puerto Rico
Serbia
Sweden
Senegal
Taiwan
Rwanda
Tunisia
Zambia
Slovenia
Sierra Leone
San Marino
Thailand
Uruguay
Portugal
Uzbekistan
Russian Federation
Turkey
El Salvador
Ukraine
Uganda
Venezuela
Dominican Republic
Namibia
Iceland
Azerbaijan
Nigeria
Bahamas
Iraq
United Arab Emirates
Jamaica
Honduras
Bolivia
Isle of Man
Kuwait
Luxembourg
Peru
Pakistan
Albania
Myanmar
Liechtenstein
Morocco
Romania
Grenada
Bangladesh
Argentina
Jordan
Norway
Mexico
Panama
Lithuania
Nicaragua
Mali
Lebanon
Mauritius
Philippines
Israel
Jersey
Malaysia
Malta
Italy
Kazakhstan
Cayman Islands
Kenya
Cambodia
Colombia
Cyprus
Oman
Latvia
Cameroon
Austria
Switzerland
Guatemala
Marshall Islands
VC (Venture Capital) Funds in Israel by industry
Restaurants
Venture Capital
Oil and Gas
Education
Transportation
Big Data
Finance
Cryptocurrency
Payments
Food and Beverage
Organic Food
Video Games
Medical
Medical Device
Wellness
Email
Internet
Social Media
Digital Media
Art
Music
Social Network
Mobile
Construction
Legal
Enterprise Software
Sports
eSports
Automotive
Hospitality
CleanTech
Travel
InsurTech
Recruiting
Mobile Advertising
Cannabis
Biotechnology
Enterprise
FinTech
Health Care
EdTech
Sustainability
Energy
Impact
Proptech
SaaS
Marketplace
Artificial intelligence
Community
Gaming
Real Estate
Retail
Mobile Apps
Infrastructure
Fashion
Beauty
Social
Web3
Photography
Clean Energy
Financial Services
B2B
Life Science
Consumer
Platforms
Publishing
Climate
Social Impact
Hardware
Android
Blockchain
Agriculture (agtech)
Manufacturing
Machine Learning
Software
Fitness
Renewable Energy
Biotech
Media (entertainment)